Interview with Stanislas Veillet on Boursier.com Stanislas Veillet, CEO of Biophytis, analyses on BOURSIER.COM the new development cycle of Biophytis and reviews the clinical successes of the COVA, SARA, MYOCA and MACA studies which are in the Biophytis pipeline. Lire l'interview sur Boursier.com Fullscreen Mode Partager cet article Share on LinkedInShare on LinkedIn Share on XShare on X Share on FacebookShare on Facebook Pin itShare on Pinterest Share on WhatsAppShare on WhatsApp Post navigationPreviousPrevious post:MAY 12, 2021NextNext post:JUNE 18, 2021